We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is a Beat in Store for MetLife (MET) This Earnings Season?
Read MoreHide Full Article
MetLife, Inc. (MET - Free Report) is set to release first-quarter 2020 earnings on May 6.
For the to-be-reported quarter, the Zacks Consensus Estimate for earnings is pegged at $1.45 per share, indicating a 2.03% dip from the year-ago reported figure. The consensus mark for revenues suggests an upside of 8.17% from the year-earlier reported number.
Factors at Play
Within the U.S. business segment, strong growth in voluntary products is likely to have aided Group Benefits premium. The company’s brand name, product sets, customer base and distribution reach might have driven sales of voluntary products. Within the Retirement and Income Solutions sub-segment, premium growth is expected to have been driven by higher pension risk transfer transactions. Within the property and casualty segment, catastrophe losses are likely to have weighed on underwriting margins. The Zacks Consensus Estimate for premium from the U.S. business is pegged at $6.82 billion, indicating an 11.8% increase from the year-ago reported figure.
The company’s Asia business is likely to have witnessed soft sales in Korea, China and India. Also, the impact of the divested business in Hong Kong and a large group case in Australia might have been a drag on overall sales.
In the EMEA business, strong sales are likely to have been seen across the region. The Zacks Consensus Estimate for EMEA business is pegged at $584 million, indicating an 11.4% decrease from the year-ago reported figure.
In Latin America, premium results should reflect a decline in annuity sales in Chile, partly offset by higher sales in Brazil and Mexico.
Moreover, the continuingperiod of low interest rates and risk asset returns is likely to have put pressure on MetLife’s investment portfolio income, increased liabilities for claims and future benefits, and escalated the cost of risk transfer measures, thereby draining profit margins.
We note that the company’s net investment income declined in 2017 and 2018. Though the same was up 2.6% in 2019, low interest rate environment might have left net investment income stressed in the first quarter because of weak investment yields.
Share repurchases made by MetLife in the to-be-reported quarter are likely to have bolstered its bottom line.
Earnings Surprise History
The company boasts an impressive earnings surprise record. Its bottom line beat estimates in three of the last four quarters and missed in one, the positive surprise being 12.67%, on average. This is depicted in the chart below:
Our proven model predicts an earnings beat for MetLife this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter
Earnings ESP: MetLife has an Earnings ESP of +0.45%.
Zacks Rank: MetLife currently has a Zacks Rank #3.
Other Stocks to Consider
Some other stocks worth considering from the insurance industry with the perfect mix of elements to surpass estimates this reporting cycle are as follows:
Kemper Corp. (KMPR - Free Report) has an Earnings ESP of +10.27% and a Zacks Rank #2.
Lincoln National Inc. (LNC - Free Report) has an Earnings ESP of +0.56% and is Zacks #3 Ranked.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
Is a Beat in Store for MetLife (MET) This Earnings Season?
MetLife, Inc. (MET - Free Report) is set to release first-quarter 2020 earnings on May 6.
For the to-be-reported quarter, the Zacks Consensus Estimate for earnings is pegged at $1.45 per share, indicating a 2.03% dip from the year-ago reported figure. The consensus mark for revenues suggests an upside of 8.17% from the year-earlier reported number.
Factors at Play
Within the U.S. business segment, strong growth in voluntary products is likely to have aided Group Benefits premium. The company’s brand name, product sets, customer base and distribution reach might have driven sales of voluntary products. Within the Retirement and Income Solutions sub-segment, premium growth is expected to have been driven by higher pension risk transfer transactions. Within the property and casualty segment, catastrophe losses are likely to have weighed on underwriting margins. The Zacks Consensus Estimate for premium from the U.S. business is pegged at $6.82 billion, indicating an 11.8% increase from the year-ago reported figure.
The company’s Asia business is likely to have witnessed soft sales in Korea, China and India. Also, the impact of the divested business in Hong Kong and a large group case in Australia might have been a drag on overall sales.
In the EMEA business, strong sales are likely to have been seen across the region. The Zacks Consensus Estimate for EMEA business is pegged at $584 million, indicating an 11.4% decrease from the year-ago reported figure.
In Latin America, premium results should reflect a decline in annuity sales in Chile, partly offset by higher sales in Brazil and Mexico.
Moreover, the continuingperiod of low interest rates and risk asset returns is likely to have put pressure on MetLife’s investment portfolio income, increased liabilities for claims and future benefits, and escalated the cost of risk transfer measures, thereby draining profit margins.
We note that the company’s net investment income declined in 2017 and 2018. Though the same was up 2.6% in 2019, low interest rate environment might have left net investment income stressed in the first quarter because of weak investment yields.
Share repurchases made by MetLife in the to-be-reported quarter are likely to have bolstered its bottom line.
Earnings Surprise History
The company boasts an impressive earnings surprise record. Its bottom line beat estimates in three of the last four quarters and missed in one, the positive surprise being 12.67%, on average. This is depicted in the chart below:
MetLife, Inc. Price and EPS Surprise
MetLife, Inc. price-eps-surprise | MetLife, Inc. Quote
Here is what our quantitative model predicts:
Our proven model predicts an earnings beat for MetLife this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter
Earnings ESP: MetLife has an Earnings ESP of +0.45%.
Zacks Rank: MetLife currently has a Zacks Rank #3.
Other Stocks to Consider
Some other stocks worth considering from the insurance industry with the perfect mix of elements to surpass estimates this reporting cycle are as follows:
Prudential Financial Inc. (PRU - Free Report) has an Earnings ESP of +0.56% and a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Kemper Corp. (KMPR - Free Report) has an Earnings ESP of +10.27% and a Zacks Rank #2.
Lincoln National Inc. (LNC - Free Report) has an Earnings ESP of +0.56% and is Zacks #3 Ranked.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>